Health Care
Home > Health Care > Doctors
Interventional Oncology
Li Jiaping
Professor,Chief physician
Overview
Clinical Interests Liver carcinoma minimally invasive therapy; Cirrhosis and portal hypertension; primary and metastasis lung cancer
Medical Education Sun Yat-sen University, Imaging and Nuclear Medicine, Ph.D
Work Experiences 2000.07 - 2011.06: The Department of Interventional radiology of the First Affiliated Hospital of Sun Yat-sen University, Attending Physician, Associate Professor and Professor 2011.6 - Persent: The Department of Interventional Oncology of the First Affiliated Hospital of Sun Yat-sen University, Professor, Director of Department and Doctoral Supervisor
Outpatient Schedule Monday morning, Wednesday morning and afternoon
Biography

Specialties: Minimally invasive therapy of malignant tumor, especially in liver carcinoma, liver metastasis tumor, primary and metastasis lung cancer, pancreatic cancer, bladder cancer and abdominal solid tumor of children, etc.  Also has abundant clinical experience in TIPSS treatment of liver cirrhosis portal hypertension and interventional treatment of hemangioma.

Membership in professional associations: President of Youth Member of Intervention Committee of Chinese Medical Doctor Association, Deputy president of the Cancer Intervention Committee, President of Youth Member of Cancer Minimally Invasive Treatment Committee of Chinese Anti-Cancer Association, Deputy President of Youth Member of Cancer Intervention Professional Committee, Deputy President of Intervention Committee of International Hepatobiliary and Pancreatic Committee, Deputy President of Asian Committee of Frozen Therapy, Executive Director of Asia-Pacific Cancer Ablation Commottee, etc. The reviewer of several SCI journals, including European Radiology,PLoS One, BMC Cancer, CVIR, JVIR, Neurosurgery, J Urology,  etc.

Publications: Published more than fifty monographs in well-known international/domestic journals as first or corresponding author, including The oncologist, Oncotarget, Journal of Vascular and Interventional Radiology, Plos One, Targeted Oncology, Tumor Biopsy, etc.

Funding: Leaders of three National Natural Science Foundation of China  and several national and provincial funding programs. The accumulated funds are more than 5 million RMBs.

 

 

 


TOP